حبة مدمجة تقلل دخول المستشفيات لمرضى القلب

A novel three-in-one medication known as a "polypill" has been put to the test in a trial of more than 200 heart failure patients, in an effort to find a new way to effectively treat the condition with fewer drugs and better health outcomes. The findings were just what the scientists had hoped for. Continue Reading Category: Heart Disease , Illnesses and conditions , Body and Mind Tags: UT Southwestern , Heart attack , Heart , Heart Failure , Heart health , Personalized medicine , clinical trials , Experimental , Age-Related